Funding Rounds
Epsilogen

Epsilogen Unknown (2022, $41M)

Epsilogen

Developer of immunoglobulin E (IgE) antibodies to treat cancer.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Unknown

Raised Amount: $41.67M

Raised Date: 2022-01-01

Investors